Nestle

Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Endpoints
Nestle
Aimmune Therapeutics
peanut allergy
Flag link:
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Yahoo/Reuters
consumer health
M&A
Merck KGaA
Nestle
Flag link:
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
GoinPharma
Nestle
Merck KGaA
M&A
consumer health
Flag link:
Bayer, its consumer health ambitions snagged, recruits Nestle executive to replace current chief
Bayer, its consumer health ambitions snagged, recruits Nestle executive to replace current chief
Fierce Pharma
Bayer
consumer health
Nestle
Flag link:
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
R&D
layoffs
Galderma
Nestle
dermatology
Flag link:
Nestlé’s health science unit inks staged acquisition of Phagesis
Nestlé’s health science unit inks staged acquisition of Phagesis
Mass Device
Nestle
Phagesis
M&A
dysphagia
devices
Flag link:
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Alzheimer's disease
Nestle
AC Immune
R&D
Flag link:
Nestle enters agreement to develop ulcerative colitis therapy
Nestle enters agreement to develop ulcerative colitis therapy
Yahoo/Reuters
Nestle
ulcerative colitis
Lipid Therapeutics
LT-02
Flag link:
Flagship's startup factory recruits AstraZeneca, Bayer and Nestlé
Flagship's startup factory recruits AstraZeneca, Bayer and Nestlé
Fierce Biotech
Flagship Ventures
AstraZeneca
Bayer
Nestle
venture capital
Flag link:
Pharma's top 10 M&A deals of 2014's first half
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
M&A
Actavis
Forest Labs
GSK
Novartis
Bayer
Merck
Mallinckrodt
Questcor Pharmaceuticals
Eli Lilly
Idenix
Nestle
Galderma
Sun Pharma
Ranbaxy
Aptalis
Abbott Labs
CFR
Flag link:
Nestle’s Galderma Deepens Ipsen Alliance for Wrinkle Smoother
Nestle’s Galderma Deepens Ipsen Alliance for Wrinkle Smoother
Bloomberg
Nestle
Galderma
Ipsen
Dysport
Azzalure
Flag link:
Nestle boosts skincare business with $1.4 bln Valeant deal
Nestle boosts skincare business with $1.4 bln Valeant deal
Yahoo/Reuters
M&A
Valeant Pharmaceuticals
Nestle
Galderma
skincare
Flag link:
Nestle and Fresenius home in on Danone Medical - sources
Nestle and Fresenius home in on Danone Medical - sources
Yahoo/Reuters
Nestle
Fresenius
Danone
M&A
Flag link:
Nestle enters biotech deal with Cellular Dynamics
Nestle enters biotech deal with Cellular Dynamics
Yahoo/Reuters
Nestle
Cellular Dynamics
Flag link:
Botox Gets $10 Billion Cheaper for Acquirers: Real M&A
Botox Gets $10 Billion Cheaper for Acquirers: Real M&A
Bloomberg
M&A
Allergan
Botox
Merck
GSK
Nestle
Flag link:
Mexico says Nestle to sell Pfizer's Mexico baby food unit
Mexico says Nestle to sell Pfizer's Mexico baby food unit
Reuters
M&A
Pfizer
infant nutrition
Mexico
Nestle
Flag link:
Nestle Forms Botanical-Medicine Venture With Li’s Chi-Med
Nestle Forms Botanical-Medicine Venture With Li’s Chi-Med
Bloomberg
Nestle
Chi-Med
traditional Chinese medicine
Flag link:
Nestle Purchase of Pfizer Unit Blocked in Mexico
Nestle Purchase of Pfizer Unit Blocked in Mexico
Bloomberg
Nestle
Pfizer
Mexico
M&A
infant nutrition
Flag link:
Nestle Wins Clearance in China for Acquisition of Pfizer Unit
Nestle Wins Clearance in China for Acquisition of Pfizer Unit
Bloomberg
China
Pfizer
M&A
Nestle
infant nutrition
Flag link:
Battling It Out for the Infant Formula Market
Battling It Out for the Infant Formula Market
Minyanville
infant nutrition
Nestle
Pfizer
Mead Johnson Nutrition
Abbott Laboratories
Flag link:

Pages